0001683168-18-000244.txt : 20180130 0001683168-18-000244.hdr.sgml : 20180130 20180129183832 ACCESSION NUMBER: 0001683168-18-000244 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180130 DATE AS OF CHANGE: 20180129 EFFECTIVENESS DATE: 20180130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Primmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001721931 IRS NUMBER: 823006157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-298274 FILM NUMBER: 18557114 BUSINESS ADDRESS: STREET 1: 1929 EAST POINTE AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 858-205-2281 MAIL ADDRESS: STREET 1: 1929 EAST POINTE AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008 D/A 1 primary_doc.xml X0708 D/A LIVE 0001721931 Primmune Therapeutics, Inc. 1929 EAST POINTE AVENUE CARLSBAD CA CALIFORNIA 92008 858-205-2281 DELAWARE None None Corporation true 2017 Paulo S Rangel 1929 East Pointe Avenue Carlsbad CA CALIFORNIA 92008 Executive Officer Director James R Appleman 1929 East Pointe Avenue Carlsbad CA CALIFORNIA 92008 Executive Officer Director Todd J Harris 1929 East Pointe Avenue Carlsbad CA CALIFORNIA 92008 Director Other Technology Decline to Disclose 06b true 0001683168-17-002861 2017-10-18 true true false 0 1525000 1525000 0 false 36 0 0 360000 A portion of the proceeds will be used to pay salaries of executive officers. false Primmune Therapeutics, Inc. /s/ Paulo S. Rangel Paulo S. Rangel President 2018-01-29